Study to Evaluate Visual Acuity Measured With the EyeQue Insight Versus a Standard Eyechart.
A Clinical Study to Evaluate Visual Acuity Measured With the EyeQue Insight Versus an Eyechart in a Healthcare Office Environment.
1 other identifier
interventional
89
1 country
1
Brief Summary
Open label exploratory study of the EyeQue Insight in healthy volunteers \>=7 years of age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2020
CompletedStudy Start
First participant enrolled
July 3, 2020
CompletedFirst Posted
Study publicly available on registry
July 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 24, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 24, 2020
CompletedMarch 24, 2021
March 1, 2021
6 months
July 1, 2020
March 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Acuity Visit 1
Variance of best-corrected (BCVA) monocular VA of each participant's OD and OS measured on the ETDRS chart and the ETDRS test of the EyeQue Insight at Visit 1.
Visit 1: Day 0
Secondary Outcomes (1)
Acuity Visit 1 and 2
Visit 1 (Day 0) and Visit 2 (Day 7)
Study Arms (1)
Visual Acuity with a Hand-held Device Supported by Mobile App.
EXPERIMENTALThe Insight will be compared to a standard ETDRS eyechart
Interventions
The Insight will be used to measure visual acuity and compared with a standard ETDRS eye chart.
Eligibility Criteria
You may qualify if:
- Male or Female
- Ages =\>7 y.o.
- Subjects that are minors (\<18 years old) must have a parent or legal guardian.
- Binocular vision
- Willing and able to give informed consent and follow all study procedures and requirements
- Fluent in English
You may not qualify if:
- Has been diagnosed within 4 weeks, or currently has signs or symptoms, of COVID-19.
- Has traveled outside the country within the last 4 weeks
- Medications:
- a. Taking medications that may affect ability to follow instructions.
- Eye Disease:
- a. Subjects with eye disease deemed by the Investigator to be inappropriate for the study such as an active eye infection.
- Subjects that:
- Lack physical dexterity to properly operate the EyeQue App on the smartphone
- Lack the ability to follow instruction
- Lack binocular vision
- Lack the ability to maintain both eyes open
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- EyeQue Corp.lead
- Eye Boutique Optometrycollaborator
Study Sites (1)
EyeQue
Newark, California, 94560, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2020
First Posted
July 16, 2020
Study Start
July 3, 2020
Primary Completion
December 24, 2020
Study Completion
December 24, 2020
Last Updated
March 24, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share